Dorsey Wright & Associates Harvard Bioscience Inc Transaction History

Dorsey Wright & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$4.0 - $5.82 $548 - $797	-137 Reduced 3.34%	3,962 $17,000
Q2 2023 Jul 26, 2023	BUY	$4.19 - $6.16 $17,174 - $25,249	4,099 New	4,099 $22,000
Q1 2022 Apr 27, 2022	SELL	$5.16 - $7.14 $39,938 - $55,263	-7,740 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$6.37 - $8.18 $6,675 - $8,572	1,048 Added 15.66%	7,740 $55,000
Q3 2021 Oct 26, 2021	BUY	$6.98 - $8.47 $3,657 - $4,438	524 Added 8.5%	6,692 $47,000
Q2 2021 Jul 23, 2021	BUY	$5.44 - $8.4 $33,553 - $51,811	6,168 New	6,168 $51,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.